WINNINGHAM RICK E (Chief Executive Officer) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/24/2026ACC: 0001302443-26-000002
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-74.97K
Net shares
Net seller
$1.47M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
74.97K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−74.97K
Price / share
$19.66
Trade value
$1.47M
% of position
4.5%
2/20/2026
1.65M→1.58M
Total
Net shares
−74.97K
Net value
-$1.47M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/20/2026 | F · Tax Withholding | −74.97K | $19.66 | $1.47M | 4.5% | 1.65M | 1.58M |
| Total | −74.97K | -$1.47M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Ordinary Shares
IndirectShares owned23.40K
Ordinary Shares
IndirectShares owned92.57K
Total
115.97K indirect115.97K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 23.40K | Indirect |
| Ordinary Shares | 92.57K | Indirect |
| Total | 115.97K | 115.97K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported